Therapeutic potential of spexin in diabetic neuropathy: Insights from in vitro and in vivo models
Experimental Physiology · 2026-08 · 111 (8) · 3800-3817
DOI: 10.1113/ep093879 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Physiology, online erschienen am 08.06.2026. Verfasst von Mehmet Refik Bahar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Dietetic, Faculty of Health Science, Osmaniye Korkut Ata University, Osmaniye, Turkey. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Peptide Hormones. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TUBITAK 1002-A Rapid Support Module Program, TUBITAK 2224-B Domestic Scientific Events Participation Support Program.
Abstract (Originalsprache)
The present study investigated the therapeutic potential of spexin (SPX) on both in vitro and in vivo models of diabetic neuropathy (DN). A total of 40 male BALB/c mice were randomly allocated into four experimental groups ( n = 10 per group): a normoglycaemic control, an untreated DN group and two SPX treatment groups (DN+SPX‐12.5 and DN+SPX‐25). To induce the diabetic state, subjects received a single intraperitoneal ( i.p. ) injection of streptozotocin (STZ) at a dosage of 150 mg/kg. Following the establishment of DN, the treatment groups were administered SPX (12.5 or 25 µg/kg/day) via i.p. injection for 15 consecutive days, whereas the untreated DN group received an equivalent volume of saline vehicle. Thermal hyperalgesia and mechanical allodynia were subsequently evaluated utilizing the hot plate, tail‐flick and electronic von Frey behavioural paradigms. in vitro assays demonstrated that SPX administration significantly restored the viability of high glucose‐exposed dorsal root ganglion cells, while in vivo assessments revealed a marked attenuation of mechanical allodynia and thermal hyperalgesia in SPX‐treated diabetic mice. Furthermore, SPX exhibited profound antioxidant and immunomodulatory properties by mitigating systemic oxidative stress and pro‐inflammatory cytokine responses, concomitantly preserving the structural integrity of the pancreatic islets. Taken together, these findings provide compelling evidence that SPX confers neuroprotective benefits in STZ‐induced DN through the modulation of oxidative stress, neuroinflammation and nociceptive sensitization, thereby highlighting its potential as a novel therapeutic agent for diabetic microvascular complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Dietetic, Faculty of Health Science, Osmaniye Korkut Ata University, Osmaniye, Turkey.
- Department of Biophysics, Faculty of Medicine, Izmir Bakırcay University, Izmir, Turkey.
- Department of Home Patient Care, School of Health Services, Inonu University, Malatya, Turkey.
- Department of Histology and Embryology, Faculty of Medicine, Inonu University, Malatya, Turkey.
- Department of Biophysics, Faculty of Medicine, Firat University, Elazig, Turkey.
- Department of Physiology, Faculty of Medicine, Inonu University, Malatya, Turkey.
ORCID-Profile: Mete Ozcan, Suat Tekin
Förderung
- TUBITAK 1002-A Rapid Support Module Program
- TUBITAK 2224-B Domestic Scientific Events Participation Support Program
Zitieren
APA
Bahar, M. R., Orhan, S. U., Tekin, C., Taslidere, A., Ozcan, M., & Tekin, S. (2026). Therapeutic potential of spexin in diabetic neuropathy: Insights from in vitro and in vivo models. Experimental Physiology, 111(8), 3800-3817. https://doi.org/10.1113/ep093879
Vancouver
Bahar MR, Orhan SU, Tekin C, Taslidere A, Ozcan M, Tekin S. Therapeutic potential of spexin in diabetic neuropathy: Insights from in vitro and in vivo models. Experimental Physiology. 2026;111(8):3800-3817. doi:10.1113/ep093879
BibTeX
@article{Bahar2026,
author = {Bahar, Mehmet Refik and Orhan, Seval Ulku and Tekin, Cigdem and Taslidere, Asli and Ozcan, Mete and Tekin, Suat},
title = {Therapeutic potential of spexin in diabetic neuropathy: Insights from in vitro and in vivo models},
journal = {Experimental Physiology},
year = {2026},
volume = {111},
number = {8},
pages = {3800--3817},
doi = {10.1113/ep093879}
}
EUVIMED